Healthy People 2010 Met Goal of Lower CVD Deaths in CKD

The government’s Healthy People program met 71% of its objectives. A particular success is a drop in cardiovascular deaths in people with chronic kidney disease. Going forward there are 24 objectives. Medscape Medical News

Routine Vaccination Decreases Varicella Incidence in Infants

Implementation of a varicella vaccination program in the United States has led to a decrease in the incidence of varicella disease in infants younger than 12 months. Medscape Medical News

XMRV-Chronic Fatigue Saga Takes Bizarre Turn

(MedPage Today) — A bitter dispute between a prominent medical researcher and her former employer, related to the largely discredited theory that a mouse virus known as XMRV causes chronic fatigue syndrome, has turned even uglier with the scientist’s arrest and jailing.

Consumer Reports Backs Dr. Oz on Arsenic in Juice

(MedPage Today) — Roughly 10% of apple and grape juice samples tested by Consumer Reports contained total levels of arsenic that exceeded federal standards set for drinking water, according to results of an investigation released today.

Risk Factors Found for Sickle Cell Silent Strokes (CME/CE)

(MedPage Today) — Silent cerebral infarction is common for children with sickle cell anemia, but now researchers have identified risk factors associated with those silent strokes, according to a large cross-sectional study.

Medicare Will Pay for Obesity Counseling

WASHINGTON (MedPage Today) — Following up on a proposal CMS issued in September, Medicare will now fully cover intensive behavioral counseling related to obesity, the agency announced late Tuesday.

HIV Not Well Controlled in U.S., CDC Says

(MedPage Today) — Despite advances in the treatment of HIV, only 28% of infected Americans have the virus under control, the CDC said.

Murray Gets Four Years in Michael Jackson Case

(MedPage Today) — Conrad Murray, MD, was sentenced Tuesday to four years in prison for his role in legendary pop singer Michael Jackson’s death in 2009.

Combination treatment improves progression-free survival in pancreatic neuroendocrine tumors

Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.

Neogenix novel antibody selected as one of Windhover’s 2011 Top 10 Projects to Watch

Neogenix Oncology, Inc. has announced that the company’s novel antibody NEO-101, which targets pancreatic and colorectal cancer cells, has been selected as one of Windhover’s 2011 Top 10 Projects to Watch.